| # | Drug | Count |
|---|---|---|
| 0 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 3 |
| 1 | ACETAMINOPHEN | 2 |
| 2 | IMMUNE GLOBULIN INFUSION (HUMAN) | 2 |
| 3 | ORITAVANCIN | 2 |
| 4 | TREPROSTINIL | 2 |
| 5 | ACETAMINOPHEN 500MG | 1 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 7 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 8 | ADRENALINUM | 1 |
| 9 | AGALSIDASE BETA | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORITAVANCIN | 2 | 0.0022 |
| 1 | HYALURONIC ACID | 1 | 0.0009 |
| 2 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 3 | 0.0004 |
| 3 | ETELCALCETIDE | 1 | 0.0003 |
| 4 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 5 | OLOPATADINE HYDROCHLORIDE OPHTHALMIC | 1 | 0.0002 |
| 6 | IMMUNE GLOBULIN INFUSION (HUMAN) | 2 | 0.0002 |
| 7 | OLOPATADINE HYDROCHLORIDE | 1 | 0.0002 |
| 8 | AGALSIDASE BETA | 1 | 0.0001 |
| 9 | TIOTROPIUM BROMIDE INHALATION SPRAY | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 2 |
| 1 | Lipoglycopeptide Antibacterial [EPC] | 2 |
| 2 | Prostacycline Vasodilator [EPC] | 2 |
| 3 | Acetylcholine Release Inhibitor [EPC] | 1 |
| 4 | Amide Local Anesthetic [EPC] | 1 |
| 5 | Antiarrhythmic [EPC] | 1 |
| 6 | Calcium [EPC] | 1 |
| 7 | Catecholamine [EPC] | 1 |
| 8 | Corticosteroid [EPC] | 1 |
| 9 | Ester Local Anesthetic [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 1 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 2 | RNA Synthetase Inhibitor Antibacterial [EPC] | 1 | 0.0001 |
| 3 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 7 | Prostacycline Vasodilator [EPC] | 2 | 0.0000 |
| 8 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |
| 9 | Catecholamine [EPC] | 1 | 0.0000 |